6th National Bioethic Conference 2017

Press coverage

Press coverage of NBC 1

'Bioethics on trial'
At the first national bioethics conference held in Mumbai, the discussions centred on India as a hot destination for clinical trials and medical research.
ANUPAMA KATAKAM

'Informed consent does not make unethical study ethical'
Interview with Dr. Richard Cash of the Harvard School of Public Health. Dr. Richard Cash is a senior lecturer in International Health at the Department of Population and International Health at the Harvard School of Public Health. He has been associated with ethics in research projects in the United States and in the developing world. In the recent past he was the principal investigator of the Applied Diarrhoeal Disease Research Project, a programme that assisted developing-country scientists in conducting their own research projects. Cash has been to India several times to help promote ethics in both domestic and international research projects. In an interview to Anupama Katakam, Cash spoke about ethical medical research in India and the global bioethics movement.

'India struggles to regulate biomedical research'
Many say India's clinical trials should be more tightly regulated
T V Padma
29 November 2005
Source: SciDev.Net

'Life-or-death guide - Norms proposed to stop futile treatment'
GS MUDUR

'Can clinical trials ever be truly ethical?'
Kalpana Sharma
Unless the rights of those who participate in clinical trials and their ability to get the best treatment in case of injury or infection are guaranteed, the trials will not be fair even if they yield useful scientific results.

'India is being projected as a global hub for clinical trials'
By Sandhya Srinivasan
Dr Vasantha Muthuswamy, who helped draw up the guidelines for biomedical research in India, discusses the difficulties of ensuring that the trials being conducted in the country do not risk the lives of Indians.